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Abstract
We explore the impact of the international epidemiological transition on educational 
attainment of males and females over the second half of the twentieth century. Using an 
instrumental variables strategy that exploits pre-existing variation in mortality rates across 
infectious diseases and gender differences in the responsiveness to the method of disease 
control, we document that health improvements associated with the transition led to larger 
gains in life expectancy for females due to their stronger immune response to vaccination. 
These relative gains were associated with greater increases in the educational attainment of 
females compared to males and account for a large share of the reduction in the education 
gender gap that took place over this period.
Keywords International epidemiological transition · Vaccination · Life expectancy · 
Education · Gender differences · Economic development
JEL Classification I15 · I24 · J16 · O11
1 Introduction
One of the greatest achievements of the world during the twentieth century has been the 
progress made toward gender equality. Comparing the role of women in economic and 
social life in 2000 relative to that in 1900 reveals the remarkable changes that occurred 
in terms of women’s legal status, political rights, access to the labor market, and other 
areas. Yet, nowhere is this change more visible than when looking at female educational 
attainment. In many countries of the world, women nowadays outperform men in all 
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levels of education, to the point that the relative under-performance of men is being 
considered an emerging problem (OECD 2015).
The progress achieved by women in terms of their educational attainment relative 
to men can be seen in Fig.  1. The figure depicts the evolution of the female-to-male 
ratio of average years of schooling over the twentieth century for a broad sample of 146 
countries based on data from Barro and Lee (2013). In the beginning of the century, this 
ratio fluctuated around 0.75, implying that women had on average only 3/4 of the years 
of schooling that men had. Following World War II, though, we see a clear upward trend 
in this ratio, as female educational attainment began to catch up. By 1990 women had 
similar levels of schooling than men in many countries of the world and subsequently 
their educational attainment began to surge ahead.
Understanding the driving forces behind this remarkable transition has been the focus 
of a growing literature in economics. Early contributions by Goldin (1995), Galor and 
Weil (1996) as well as Goldin et al. (2006) have stressed the role of improved labor mar-
ket opportunities for women. More recent work by Chiappori et al. (2009), Fernandez 
and Wong (2011) and Reijnders (2018) have highlighted changes in marriages patterns 
as an important factor. Fernandez et al. (2004), Beaman et al. (2012), Fernandez (2013), 
and Hazan and Zoabi (2015) have emphasized the importance of changing social norms 
and the elimination of biases regarding the role of women in society. Lagerlof (2003) as 
well as Doepke and Tertilt (2009) have underscored the role of improvements in wom-
en’s rights. Greenwood et  al. (2016) have stressed the role of the decline in the price 
of household durable goods, which freed women from housework. The literature has 
also explored the role of some medical advances in raising female schooling, such as 
the introduction of the birth control pill (Goldin and Katz 2002) and improvements in 
maternal health (Albanesi and Olivetti 2016).
Within this literature, most of the existing contributions have focused on the experi-
ences of developed countries and particularly on the case of the United States. When 
it comes to the evolution of the education gender gap, though, developed countries do 
not necessarily provide the most striking examples. This can been seen in Fig. 2 where 
we present the female-to-male ratio of average years of schooling separately for low-
income, middle-income and high-income countries in 1900, 1950 and 1990. Despite the 
big differences in terms of economic development between these groups of countries, 
the figure shows a relative rise in female educational attainment over the second half of 
the twentieth century in all three groups. At the same time, the rise appears to have been 
Fig. 1  Global evolution of the 
education gender gap. Notes 
This figure depicts the global 
evolution of the education 
gender gap measured as the 
female-to-male ratio of average 
years of schooling. The data are 
from Barro and Lee (2013) and 
reflect the schooling levels of the 
cohort that was 5–9 years old 
in the respective year. For the 
construction of the global series 
we average the values reported 
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more rapid in low- and middle-income countries, where many of the aforementioned 
factors have played a less important role.
In this paper we argue that the similarity in the timing of reductions in the educa-
tion gender gap across countries can be explained by the global health improvements 
that took place after World War II. We explore this hypothesis, as health improvements 
have commonly been argued to promote educational attainment. Healthier individuals, 
who expect to live longer and more productive lives, are bound to have stronger incen-
tives to invest in their own education. Similarly, parents who have healthier children 
are more inclined to invest in their children’s education. The nature of the relationship 
between health improvements and educational attainment has been highlighted in a 
series of theoretical models starting with Ben-Porath (1967) and more recent contribu-
tions by Boucekkine et al. (2002), Kalemli-Ozcan (2002), Cervellati and Sunde (2005, 
2015), Soares (2005), Hazan and Zoabi (2006) and de la Croix and Licandro (2012). At 
the same time, Soares (2006), Bleakley (2007), Jayachandran and Lleras-Muney (2009), 
Lucas (2010), Oster et al. (2013) and Hansen and Strulik (2017) have provided empiri-
cal evidence in support of this relationship.
Following the conclusions from this line of research, we would expect that if female 
health improves more than male health, female schooling will rise faster than male school-
ing and the gender gap in educational attainment, observed initially, will eventually be 
eliminated. While this hypothesis has not been explored in the literature so far, there are 
good reasons to consider it as a potential explanation for the evolution of the education 
gender gap in the post-war period. As shown in Table 1, a simple comparison of the evolu-
tion of life expectancy at birth, a broad measure of a population’s health status, and average 
years of schooling of males and females over the twentieth century indeed suggests this 
pattern. While up until 1950 the ratios between males and females in terms of life expec-
tancy and average years of schooling were fairly constant, in the subsequent years we see 


























Fig. 2  The closing of the education gender gap in different country groups. Notes This figure depicts the 
education gender gap measured as the female-to-male ratio of average years of schooling at three points in 
time (1900, 1950, 1990) for the cohorts that were 5–9 years old in the respective years. It does that sepa-
rately for low-income, middle-income and high-income countries. The education data are from Barro and 
Lee (2013). The income groups are defined according to the World Bank classification
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As the similarity in the time trends of life expectancy and average years of schooling 
is only suggestive, in our analysis we explore more carefully the link between the two by 
exploiting exogenous variation in life expectancy triggered by the so-called International 
Epidemiological Transition (IET). This term refers to the period of rapid decline in mortal-
ity from previously highly fatal infectious diseases which started after the end of World 
War II and resulted in unprecedented improvements in life expectancy around the globe 
(Becker et al. 2005; Cutler et al. 2006). These improvements were brought forward by a 
series of important medical innovations related to the development of vaccines, antibiotics 
and other treatment methods. Largely products of medical research in developed countries, 
these innovations diffused quickly across countries following the coordinated efforts by the 
United Nations and the World Health Organization. As a consequence of this diffusion pro-
cess, many infectious diseases, which previously had affected large shares of the world’s 
population, where largely eradicated or brought under control within a few decades.
Our analysis builds upon prior work in the literature that has utilized the exogenous 
nature of the IET-related health improvements from the perspective of individual countries 
to analyze their impact on various economic and social outcomes (Acemoglu and Johnson 
2007; Cervellati and Sunde 2011; Hansen 2013). Similar to this line of work, we exploit 
variation in the disease environment across countries prior to the onset of the IET with 
the rationale that the introduction of the new methods of disease control should have had a 
larger impact in places where mortality from infectious diseases was initially higher. This 
prior variation allows us to estimate the effects of the IET-related health improvements 
with an instrumental variables strategy similar to Acemoglu and Johnson, where the poten-
tial health improvements given the initial mortality environment are used as an instrument 
for the actual ones. We extend this analysis by noting an important dimension that the lit-
erature has until now largely overlooked: the fact that the IET-related health improvements 
were different for men and women. Employing a similar instrumental variables strategy, 
we demonstrate that women benefited more than men in terms of life expectancy from the 
medical advances associated with the IET. This in turn resulted in differential increases in 
Table 1  Life expectancy and educational attainment, 1900–1990
This table reports the levels of life expectancy at birth and average years of schooling for males and females 
in selected years. The reported values are simple averages across 28 countries for which life expectancy 
data are available before 1920. The average years of schooling figures are from Barro and Lee (2013) and 
correspond to the cohort that was 5–9 years old in the respective years. The life expectancy data are from 
the human mortality database (http://www.morta lity.org/) and the human lifetable database (http://www.lifet 
able.de/)
Year Life expectancy 
at birth, females
Life expec-













1900 46.3 43.7 1.059 5.0 5.5 0.919
1913 51.0 48.1 1.059 5.5 6.0 0.906
1928 55.7 52.7 1.056 6.4 7.2 0.894
1939 60.0 56.0 1.071 7.3 8.0 0.908
1950 66.6 62.2 1.071 8.9 9.5 0.931
1964 73.0 67.2 1.086 11.2 11.3 0.990
1977 75.9 69.2 1.098 12.2 12.0 1.019
1990 78.3 71.5 1.094 12.7 12.2 1.042
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female and male schooling and contributed to sizeable reductions in the pre-existing educa-
tion gender gap.
In our analysis we particularly explore the role of vaccines in giving rise to these dif-
ferential gains in life expectancy and schooling. This is motivated by a growing medical 
literature, which has demonstrated the existence of biological differences between males 
and females in their immune responses to vaccines and that vaccines are more effective 
in providing immunity to females (Cook 2008; Klein et al. 2010). This important conclu-
sion about gender differences in vaccine efficacy stands in contrast to antiviral and anti-
bacterial drugs for which the literature has not documented any systematic differences in 
their effectiveness across genders. In light of this evidence, we exploit variation in the role 
of vaccines as a method of disease control for different infectious diseases by separating 
the IET-related mortality reductions into those that can be attributed at least partially to 
the introduction and diffusion of vaccines and those that were clearly due to other medi-
cal innovations. Following this approach, we document that women experienced larger 
increases in terms of life expectancy and years of schooling than men in cases where mor-
tality from infectious diseases was subsequently brought under control with the help of 
vaccines. We also show that in cases where mortality reductions were driven by other med-
ical innovations, the resulting increases in life expectancy and schooling were similar for 
women and men.
Taking into account the gender-specific nature of the IET-related health improvements 
allows us to explain a sizeable share of the reduction in the education gender gap that 
occurred across countries after World War II. Based on our main estimates we are able to 
explain 39% of the actual life expectancy increases of women and 33% of those of men. 
In terms of educational attainment, the estimated effects correspond to 26% and 21% of 
the observed increases in female and male education. These differential increases in male 
and female education in turn imply that the differential impacts of the medical innovations 
associated with the IET on male and female health can account for approximately 80% of 
the observed global reductions in the education gender gap.
Beyond establishing the quantitative importance of this link between the IET and the 
education gender gap, we also subject it to an extensive series of robustness checks. In 
particular, we repeat our regression analysis with different measures of educational attain-
ment, different notions of life expectancy and different groups of infectious diseases, all 
of which yield similar results. We also show that the results do not hinge on any of the 
particularities of our regressions setup. Moreover, we consider the role of alternative fac-
tors that may have affected the relative rise in female schooling and show that our results 
are robust to controlling for these factors. In addition, we demonstrate that our findings are 
not driven by differences in the health-education elasticity across genders and that female 
schooling appears equally responsive to life expectancy changes as male schooling. Finally, 
we show that the gender-specific effects of the IET on life expectancy and the positive rela-
tionship between life expectancy and educational attainment for males and females can be 
observed over the post-war period not only across countries but across U.S. states as well.
Going one step further, we also study the broader macroeconomic implications of the 
differential improvements in male and female health that resulted from the IET. Focusing 
on the impact that these health improvements had on GDP per capita, we show that this 
impact was clearly positive in the case of health improvements that benefited females more 
than males. We further show that this positive impact was primarily observed in countries 
that had already undergone the demographic transition at the time of the IET and where 
42 Journal of Economic Growth (2020) 25:37–86
1 3
fertility was already low. Taken together these results suggest that policies targeted at 
improving female health can also yield broader benefits in terms of economic development.
To establish the aforementioned results we proceed as follows. Section 2 reviews the 
evidence from the medical literature on gender differences in terms of infectious diseases 
and vaccination more specifically. Section  3 outlines the empirical strategy that we fol-
low in the paper. Section 4 describes the data that we use. Section 5 presents our baseline 
results regarding the effect of the IET-related health improvements on educational attain-
ment of men and women. Section 6 discusses a series of robustness checks on our base-
line results, while Sect. 7 considers the role of other factors and different mechanisms in 
accounting for the relative rise in female schooling. Section  8 explores the relationship 
between health improvements and educational attainment for men and women based on 
data from U.S. states. Section 9 provides evidence regarding the effects of improvements 
in male and female health on GDP per capita. Section 10 offers some concluding remarks.
2  Gender differences related to infectious diseases
The fact that immune responses to pathogens differ between men and women has been 
long recognized in the medical literature (Grossman 1985). Men generally tend to exhibit 
weaker immune responses compared to women. This makes them more susceptible to con-
tract infectious diseases and to have subsequently more severe disease outcomes. In this 
section we summarize the key evidence regarding the different ways in which men and 
women are affected by infectious diseases and how they respond to vaccination. These dif-
ferences across genders are later on explored in our empirical analysis.1
The greater susceptibility of men to infectious diseases compared to women has been 
documented in a large number of clinical studies and it is often referred to in the literature 
as infectious diseases exhibiting a ‘male bias’ (Klein 2004). Recent survey articles review-
ing these studies highlight how the male bias applies to a wide range of infectious dis-
eases (Muenchhoff and Goulder 2014; Giefing-Kroell et al. 2015). For some diseases, such 
as tuberculosis, this bias is so pronounced that the number of incidences among males is 
almost twice that among females (World Health Organization 2019). The male bias is also 
evident when looking at mortality from infectious diseases. This was first shown by Owens 
(2002) using data from the United States and later by Lozano et al. (2012) based on vital 
statistics from 187 countries reported in the Global Burden of Disease Study. Comparing 
gender-specific mortality rates for 235 causes of deaths between 1990 and 2010 Lozano 
et al. report that mortality rates are on average 13% higher for males than for females across 
the 27 most important infectious diseases.
While traditionally some authors have attributed the higher prevalence of infectious 
diseases among males to behavioral or environmental factors, recent studies have cast 
doubt on the relative importance of these factors (Borgdorff et  al. 2000; Guerra-Silveira 
and Abad-Franch 2013) Instead there is increasing evidence that attributes the male bias 
to physiological differences related to sex hormones and chromosomes. In particular, the 
fact that females have two X chromosomes, a maternal and a paternal one with a varying 
1 As this paper relates biological differences between men and women to educational outcomes in a given 
social context, we prefer to use the term ‘gender’ in most of the paper to refer to these differences. When 
discussing the evidence from the medical literature in this section, however, we also use the term ’sex’ in 
order to be consistent with the medical terminology.
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pattern of expression, contributes to a biological advantage due to the process of chromo-
some inactivation (Migeon 2006; Libert et  al. 2010). The role of sex hormones, on the 
other hand, is evident by comparing the male-to-female ratios of incidences and mortality 
rates at different ages (Guerra-Silveira and Abad-Franch 2013; Giefing-Kroell et al. 2015). 
These ratios have been shown to peak during puberty and reproductive ages, when the vari-
ation in sex hormone levels between males and females is the highest. The conclusion that 
the male bias in disease susceptibility and mortality from infectious diseases is related to 
variation in sex hormones has also been strongly supported by laboratory experiments with 
animals and specific case studies with humans.2,3
These biological differences between men and women are not limited to infectious 
disease outcomes. They have also been shown to affect acquired immunity levels follow-
ing vaccination. As it has been documented in a series of studies for a variety of vaccines 
(Stanberry et al. 2002; Ovsyannikova et al. 2004; Kennedy et al. 2009), vaccine efficacy 
tends to be higher among women. This means that the relative reduction in disease suscep-
tibility of a vaccinated group of individuals, compared to a non-vaccinated one, is larger 
for women. While early studies focused on the cases of particular vaccines, more recent 
work has established that females generally exhibit stronger antibody responses following 
vaccination, as highlighted in the review articles by Cook (2008) and Klein et al. (2010).
These gender differences in vaccine efficacy have also been shown to be substantial. For 
example, Engler et al. (2008) report that in the case of influenza the antibody response of 
females to a half dose of the vaccine is comparable with the antibody response of males to 
the full dose. What is important to note here is that this pattern is not due to differences in 
the vaccine doses administered to men and women. In fact, the standard medical practice is 
to administer the same dose universally (Poland et al. 2011).
Just like in the case of the male bias in disease susceptibility, there is evidence that the 
stronger female immune response to vaccines can be attributed to sex hormones. Specifi-
cally estrogens have been shown to stimulate the activity of immune cells while testoster-
one has been shown to suppress it (Furman et al. 2013; Sakiani et al. 2013).4 The impor-
tance attributed to the role of sex hormones is also reflected in the common finding that 
immune responses to vaccines are similar for pre-pubertal boys and girls (Davidkin et al. 
1995; Wu et al. 1999). It is also consistent with a stronger female immune response among 
young adults (van der Wielen et al. 2006; Hoehler et al. 2007), which weakens above the 
age of 60 (Wolters et al. 2003; Cook et al. 2006). Beyond the role played by sex hormones, 
differences in vaccine efficacy between males and females have also been linked to genetic 
factors (Fish 2008; Poland et al. 2011).
These well-established gender differences in the effectiveness of vaccines against infec-
tious diseases contrast with the evidence on drugs and other methods of disease control. In 
their analysis of the effectiveness of 113 drugs Simonovsky et al. (2019) find no systematic 
differences between men and women. Only for drugs acting on the central nervous system, 
2 Experiments with mice have shown, for instance, that treatment of female mice with testosterone reduces 
their resistance to parasites and increases their disease burden (Cernetich et al. 2006), whereas castration 
renders male mice more resistant (Wunderlich et al. 2002; Krucken et al. 2005).
3 Human case studies, for example, have shown that castrated males exhibit lower mortality rates from 
tuberculosis than males with intact genitalia (Hamilton and Mestler 1969), while women who underwent 
surgical removal of the ovaries have higher rates of tuberculosis mortality than the rest of the female popu-
lation (Svanberg 1982).
4 Animal studies, such as those of Gillgrass et al. (2005) and Zhang et al. (2008), have provided support for 
the role of sex hormones in the immune response to vaccines as well.
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such as anti-psychotic drugs and antidepressants, as well as beta-blockers, reducing the 
heart rate and systolic blood pressure there is weak evidence for more beneficial effects in 
women compared to men (Franconi et al. 2007). For antivirals, antibiotics and other drugs 
acting on the immune system, though, there is no evidence of clear differences in effective-
ness between men and women.
Overall these medical studies underscore an important pattern: Immune responses of 
men and women to infectious diseases are different and this is true for both exposure to 
the naturally occurring pathogens as well as to the associated vaccines. These differences 
appear to be rooted largely in biological differences related to sex hormones and chromo-
somes. This suggests that public health interventions to control infectious diseases are 
expected to trigger larger mortality reductions among females than among males.5 This 
should be the case particularly for vaccination campaigns against infectious diseases, 
which should be more effective among females based on the aforementioned evidence. Yet, 
this should not necessarily apply to other public health campaigns aimed at controlling 
infectious diseases which do not rely on vaccination.
Looking at historical mortality data from the United States provides some first evidence 
in line with this prediction. Figure 3a displays the evolution of the population-wide mor-
tality rates over the course of the twentieth century for two groups of infectious and para-
sitic diseases: vaccine-preventable diseases for which vaccines played a role as a method 
of control, and non-vaccine-preventable diseases for which vaccines did not play a role as 
a method of control. Figure 3b displays for the same two groups of diseases the ratio of 
female mortality rates relative to the corresponding rates for males.
As Fig. 3a highlights, mortality rates from both groups of infectious diseases declined 
dramatically during the twentieth century. As Fig. 3b reveals, though, the evolution of the 
female-to-male ratio of mortality rates from these two groups of infectious diseases was 
different. Starting around the 1930s, female mortality from vaccine-preventable infec-
tious diseases clearly fell more than male mortality, while a relative decrease of this sort 
is not visible for non-vaccine-preventable infectious diseases.6 In the following section we 
describe how we are going to exploit the role of vaccines versus other methods of disease 
control for different infectious diseases in the context of our empirical strategy.
3  Empirical strategy
Our empirical analysis builds on the approach of Becker et al. (2005), and Acemoglu and 
Johnson (2007). These authors investigate the country-wide effects of the large health 
improvements that took place over the second half of the twentieth century following the 
IET. These improvements were triggered by the global spread of western medical innova-
tions after World War II, which led to a more effective control of infectious diseases and 
a sharp decline in mortality rates from these diseases all over the world. This resulted in 
6 The sharp increases in the female-to-male ratio for non-vaccine-preventable diseases at the end of the 
period is simply driven by the mortality rates for men and women approaching zero.
5 This is provided that these campaigns are equally effective at targeting males and females. As docu-
mented in World Bank (2012), there is no evidence for gender discrimination in access to preventative 
health services, such as vaccination. A more recent report on childhood immunization by the World Health 
Organization (World Health Organization 2016) does not find any evidence of gender differences in immu-
nization rates even among the world’s poorest countries.
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countries where the mortality burden from infectious diseases was the highest prior to the 
IET benefiting the most in terms of mortality reductions from the new methods of disease 
control. This observation permits an identification strategy, originally proposed by Acemo-
glu and Johnson, for estimating the effects of the IET-related health improvements. This 
can be done in the context of an instrumental variables regression where potential changes 
a
b
Fig. 3  a Mortality rates from vaccine- and non-vaccine-preventable diseases. Notes This figure depicts 
the evolution of mortality rates from two groups of infectious and parasitic diseases in the U.S., calculated 
based on data from the U.S. Vital Statistics. The rates reflect mortality of the entire U.S. population. The 
group of vaccine-preventable diseases includes diphtheria, influenza, measles, pneumonia, tuberculosis, 
smallpox and whooping cough. The group of non-vaccine-preventable diseases includes cholera, diarrhea, 
malaria, plague, scarlet fever, typhoid fever and typhus. b Gender differences in mortality from vaccine- and 
non-vaccine-preventable diseases. Notes This figure depicts the female-to-male ratio of mortality rates from 
two groups of infectious and parasitic diseases in the U.S., calculated based on data from the U.S. Vital Sta-
tistics. The rates reflect mortality of the total female and male U.S. population. The group of vaccine-pre-
ventable diseases includes diphtheria, influenza, measles, pneumonia, tuberculosis, smallpox and whooping 
cough. The group of non-vaccine-preventable diseases includes cholera, diarrhea, malaria, plague, scarlet 
fever, typhoid fever and typhus
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in mortality from infectious diseases, determined by the initial variation in mortality rates, 
serve as an instrument for the actual health improvements that took place in each country.
Our approach builds on this identification strategy, but differs from previous contribu-
tions in the literature as we consider the gender-specific nature of the IET-related health 
improvements and their effects on educational attainment. In order to do so, we take into 
consideration whether the initial mortality environment in a given country was dominated 
by infectious diseases that were subsequently controlled by vaccination or by other meth-
ods. This distinction allows us to explore the patterns discussed in the previous section 
regarding how different public health interventions aimed at controlling infectious diseases 
can have different effects on males and females depending on the method of disease con-
trol. Specifically, in countries where the mortality environment prior to the IET was domi-
nated by infectious diseases that were at least partially brought under control with the intro-
duction of new or improved vaccines, we would expect to see bigger health improvements 
for females than for males. In contrast, in countries where the mortality environment prior 
to the IET was dominated by infectious diseases that were brought under control thanks 
to other medical innovations, we would expect to see similar improvements in female and 
male health.
As our interest is to estimate the effects of these health improvements on educational 
attainment, we follow an estimation strategy similar to Hansen (2013). We use life expec-
tancy at birth as a broad measure of health and average years of schooling as a proxy for 
educational attainment. We focus on long-run changes in these variables and we estimate 
how they relate with each other for men and women in a long-differences panel with two 
time periods, before and after the IET. For most of our analysis, we take these two time 
periods to be 1940 and 1980. Specifically, our main estimation equation is:
AYSgct denotes the average years of schooling of a given cohort of gender g in country 
c which started school in year t and LEgct denotes the life expectancy at birth of gender 
group g in country c in year t. The specification includes gender-country fixed effects, gc, 
and year fixed effects t. Thus, our fixed-effects panel regression with two time periods is 
equivalent to a specification in first differences. Conditional on these fixed effects, a pos-
itive  coefficient would suggest that life expectancy increases between 1940 and 1980, 
which reflect improvements in the general health of the population, were associated with 
increases in educational attainment for men and women.
To account for the possible endogeneity bias in the estimation of , we employ the 
identification strategy described above and estimate Eq.  (1) with two-stage least squares 
(2SLS). Specifically we instrument LEgct based on the first-stage specification:
The subscripts g, c and t again denote gender, country, and year, while the subscript d 
denotes different infectious diseases. Mdct is the potential mortality rate from infectious dis-
ease d in country c and year t given the state of the available medical technology. Follow-
ing Acemoglu and Johnson (2007), we take Mdct in 1940 to be equal to the actual country-
specific mortality rates in that year, before the IET, and in 1980 to the mortality rates at the 
global health frontier. As Mdct takes the same values for all countries in 1980, changes in 
(1)AYSgct =  ⋅ LEgct + gc + t + ugct.










Mdct + gc + t + gct.
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this variable between 1940 and 1980 do not capture the actual changes in mortality from 
disease d. Instead they reflect the potential changes in mortality from a given infectious 
disease that could be achieved as a consequence of the IET-related medical innovations 
and their global diffusion after 1940. Thus, changes in Mdct are treated as a predictor for the 
actual changes in mortality from infectious diseases that occurred across countries between 
1940 and 1980 and this predictor is used as an instrument for the associated changes in life 
expectancy.
To assess the role played by the method of disease control, the mortality rates from 
different infectious diseases are in some cases summed up altogether, as in Eq.  (2), and 
in some cases combined into two groups, as in Eq.  (3). The two groups correspond to a 
group of vaccine-preventable diseases which we denote by VP and refer to simply as the 
VP group, and a group of non-vaccine-preventable diseases, which we denote by NVP and 
refer to as the NVP group. These mortality rates are interacted with a dummy variable for 
all female observations, Ifg, in order to estimate the differential effects of the potential mor-
tality reductions across genders. The specification also includes gender-country and year 
fixed effects in line with Eq. (1).
As larger changes in Mdct over time indicate greater potential reductions in mortality from 
infectious diseases, they should be associated with larger increases in life expectancy. 
Thus, we would expect both VP and NVP to be negative. Comparing these effects between 
males and females, we would expect the interaction coefficient VPf  to be negative. This is 
because, in light of the evidence from the medical literature discussed in Sect. 2, reduc-
tions in potential mortality rates due to the introduction of vaccines are bound to increase 
life expectancy for women more than for men. At the same time, we expect the interaction 
coefficient NVPf  to be zero, as there is no evidence of reductions in potential mortality 
rates due to other methods of disease control to have differential effects on male and female 
life expectancy.
The unbiased estimation of the key coefficients of interest in our empirical setup 
requires the exogeneity of changes in the potential mortality rates, Mdct , for the different 
groups of infectious diseases over our sample period. In that respect, the crucial assump-
tion is that the initial mortality rates, which reflect the mortality environment in each coun-
try prior to the IET, are uncorrelated with other time-varying country and gender specific 
characteristics that influence education through channels other than life expectancy. The 
validity of this assumption is investigated as part of our robustness analyses. There we con-
trol for several time-varying correlates of male and female health and educational attain-
ment, the omission of which could bias our results. Other factors giving rise to persistent 
differences in the level of educational attainment of males and females in a given country 
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4  Data
For our main regression analysis we use a panel data set covering 75 countries over two 
time periods.7 As already mentioned in the previous section, the two time periods cor-
respond to the years 1940 and 1980 in most regressions.8 We focus on changes between 
these two time periods in order to assess the impact of the medical innovations associated 
with the IET on life expectancy and schooling before the start of the global HIV/AIDS 
epidemic, as in Acemoglu and Johnson (2007), Cervellati and Sunde (2011) and Hansen 
(2013). As we are interested in the extent to which these medical advances had different 
effects on the outcomes of males and females, our data set includes for each country and 
year two observations, one for the female population and one for the male population. This 
leads to a total sample size of 300 observations.
Section A of the appendix lists the 75 countries that are included in our main sample. 
They span well all regions of the world with the exception of Sub-Saharan Africa for which 
we have data for only two countries. In this section, we briefly describe the key variables 
of interest, namely average years of schooling, life expectancy at birth and mortality rates 
for different infectious diseases. Further information on the data sources for these variables 
and for all additional data that we employ in our analysis can be found in Section B of the 
appendix.
To measure educational attainment, we use the average years of schooling data provided 
by Barro and Lee (2013), which are gender- and cohort-specific. Following the approach 
of Hansen (2013), we focus on the cohort of individuals that were between 5 and 9 years 
old in the two respective time periods (1940, 1980) and measure their educational attain-
ment 10 years later (1950, 1990). These are the cohorts of boys and girls that started with 
their formal schooling between 1937 and 1941, and between 1977 and 1981, respectively.9 
By comparing them we can assess how educational attainment in different countries was 
affected by the life expectancy improvements that resulted from the IET.
Data on life expectancy at birth in 1940 are drawn mainly from the various editions of 
the UN Demographic Yearbook. This is supplemented with additional sources for selected 
countries, as explained in Section B of the appendix. The respective information for 1980 
is obtained from the electronic version of World Population Prospects database of the UN 
Population Division. We furthermore collect information on life expectancy at higher ages. 
The sources for these data are the same as for life expectancy at birth, namely UN Demo-
graphic Yearbooks for 1940 and World Population Prospects for 1980.
The information on mortality rates from infectious diseases that we use in our main 
analysis is drawn from Acemoglu and Johnson (2007). The authors report disease-spe-
cific mortality rates for 13 infectious diseases in 1940. In line with our empirical strategy 
described in Sect. 3, we either sum up the mortality rates for all these diseases or consider 
separately the sum of mortality from diseases that fall in the VP and NVP groups. These 
groups are defined based on the role that vaccines played as a method of disease control 
during the post-war era. The VP group of vaccine-preventable diseases includes diseases 
for which vaccines played at least partially a role as a method of disease control. These 
are: diphtheria, influenza, measles, pneumonia, smallpox, tuberculosis, whooping cough. 
8 We also collect data for several other years. These are used in the appendix where we report regression 
results for different time periods and for a multi-period panel.
9 As part of our robustness analysis, we also consider educational attainment for other schooling cohorts 
and explore the impact of life expectancy changes separately on primary, secondary and tertiary education.
7 In Sect. 8 we also go beyond the country level analysis and conduct a similar analysis based on data from 
U.S. states.
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The NVP group of non-vaccine-preventable diseases includes the remaining six diseases 
for which vaccines were not important as a method of control. These are: cholera, malaria, 
plague, scarlet fever, typhoid fever, typhus. Section C of the appendix provides detailed 
information on the characteristics of each disease and the key methods of control based on 
which we assign the 13 diseases to these two groups.10
For the year 1980 we do not collect data on disease-specific mortality rates for all coun-
tries. This is because our potential mortality instrument should not reflect the actual coun-
try-specific mortality environment in that period, but the conditions at the global health 
frontier. In particular, for our main analysis we follow Acemoglu and Johnson (2007) and 
assume that the frontier mortality rates in 1980 were zero for all infectious diseases. As an 
alternative to this approach, we assume that all countries experienced the same proportion-
ate reductions in mortality between 1940 and 1980, rather than reaching the same level in 
1980. In this case, the potential mortality rate for each disease in 1980 is taken to be equal 
to the country-specific rate in 1940 scaled down by the average rate at which mortality for 
that disease fell at the global level. As a second alternative we assume that the mortality 
rates for all countries in 1980 were equal to the values observed in the United States in that 
year, which were close to, but not equal to zero. As a third alternative we assume that the 
mortality rates for all countries in 1980 were equal to the average values observed in other 
countries at the health frontier in that year.11 Constructed as the difference between the 
country-specific mortality rates in 1940 and the rates at the global health frontier in 1980, 
our mortality figures reflect the potential changes in mortality rates from infectious dis-
eases that could have been achieved in each country following the IET. These can function 
as an instrument for the actual changes in life expectancy. This is because potential changes 
in mortality rates are correlated with actual changes in mortality rates, which in turn deter-
mine the evolution of life expectancy, but are not affected by it.
We should note here that the figures we have for potential mortality are not gender-
specific, but refer to the total population of each country. Neither Acemoglu and Johnson 
(2007) nor the original sources of their data provide any gender-specific mortality rates for 
our sample of countries. When estimating our first-stage regression specifications, there-
fore, we assign the same figure to the male and female observations in each respective 
country and only allow their effect on life expectancy to differ across genders, as indicated 
in Eqs. (2) and (3). For our robustness analysis in Sect. 6.2, however, we do employ gender-
specific mortality rates from infectious diseases in 1940, which we impute from informa-
tion available for selected countries. This allows us to compare the estimated effects based 
on gender-specific and non-gender-specific mortality rates. We perform a similar compari-
son when we conduct our analysis based on data from U.S. states in Sect. 8, for which we 
have gender-specific mortality rates.
Table 2 shows the descriptive statistics for all key variables. For average years of school-
ing and life expectancy at birth the statistics are reported separately for males and females. 
As these figures clearly indicate, both schooling and life expectancy increased substantially 
10 We should emphasize here that for our grouping of diseases we do not need to consider the relative 
importance of vaccines versus other measures of disease control, such as antibiotics. For any infectious 
disease for which vaccines played a role as a method of control, we should expect to see some differential 
effects on male and female life expectancy.
11 Given their important role in drug development, we take these countries to be France, Germany, Switzer-
land and the United Kingdom.
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between 1940 and 1980 and these increases were larger for females than for males. The 
exact nature of this relationship is what we investigate in the next section.
5  Baseline regression results
Table 3 presents the results from the estimation of our main specification with 2SLS. Panel 
A shows the results of the first-stage estimation based on variants of Eqs. (2) and (3), while 
panel B shows the results of the corresponding second-stage estimation of Eq. (1). Stand-
ard errors, reported in brackets, are clustered at the gender-country level in line with the 
employed fixed-effects.
In column 1 we present a simple variant of the first-stage specification where we omit 
the interaction term with the female dummy and we do not split the mortality rates into dif-
ferent disease groups. Instead we look at the overall effect of the potential mortality reduc-
tions from the 13 infectious diseases on life expectancy at birth. As the estimated coef-
ficient indicates, the improvements in the mortality environment that took place globally 
between 1940 and 1980 as result of the IET had a large and statistically significant effect 
on life expectancy. The coefficient implies that on average the mortality reductions contrib-
uted to an increase in life expectancy at birth by 7 years, which is similar to the magnitude 
reported by Acemoglu and Johnson (2007).
In column 2 we allow the effect of the potential mortality reductions to vary between 
males and females by including in the specification the interaction term between potential 
mortality and the female dummy. The estimated coefficient for the interaction term is neg-
ative and statistically significant, indicating that female life expectancy, on average, rose 
faster between 1940 and 1980 than male life expectancy in response to the same improve-
ments in the mortality environment. Specifically, the estimated coefficients of −12.9 and 
−4.9 imply that male life expectancy increased on average by 5.6  years and female life 
expectancy increased by 7.8 years as a consequence of the IET-related medical advances. 
Table 2  Descriptive statistics of key variables
This table shows the descriptive statistics for the key variables in our analysis for our main sample of 75 
countries. A precise definition of each variable and the exact data sources are provided in Section B of the 
Appendix
Variable Mean SD Min Max
Mortality, overall, 1940 0.436 0.274 0.0326 1.126
Mortality, VP-group, 1940 0.363 0.241 0.03 0.909
Mortality, NVP-group, 1940 0.0635 0.14 0 0.853
Life expectancy at birth, females, 1940 49.61 12.17 28.44 70.72
Life expectancy at birth, males, 1940 46.8 11.19 25.46 66.97
Life expectancy at birth, females, 1980 69.64 7.5 51.51 79.6
Life expectancy at birth, males, 1980 64.07 6.52 48.64 73.56
Avg. years of schooling, females, 1940 4.26 2.54 0.146 9.17
Avg. years of schooling, males, 1940 4.54 2.51 0.144 11.16
Avg. years of schooling, females, 1980 7.71 2.17 3.13 11.61
Avg. years of schooling, males, 1980 7.69 1.94 3.21 11.44
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This corresponds to 33% and 39% of the actual life expectancy increases for males and 
females respectively observed on average over this period in our sample of countries.
When interpreting these estimates, it is important to keep in mind that the relatively 
larger estimated effect for females implies that female life expectancy increased more in 
response to the same potential rather than the same actual reduction in mortality. The actual 
changes in mortality rates for males and females are by construction already reflected in 
the corresponding life expectancy figures. The potential changes in mortality rates, how-
ever, will only be partially reflected in life expectancy, as by 1980 not all countries in our 
sample had achieved zero mortality rates from these 13 major infectious diseases. Still the 
fact that female life expectancy gains were systematically higher across countries suggests 
that some of the IET-related medical advances clearly benefited women more than men.
To understand better the source of these stronger life expectancy gains for females, in 
column 3 we estimate the first-stage specification distinguishing between potential mortal-
ity reductions in terms of vaccine-preventable diseases (VP group) and non-vaccine-pre-
ventable diseases (NVP group). We also allow the effects of these reductions to vary across 
genders. As we can see from the estimated coefficients, the potential reductions in mortal-
ity from both groups of diseases were associated with significant increases in life expec-
tancy. Moreover, as the interaction terms with the female dummy reveal, the same potential 
reductions in mortality were associated with significantly larger increases in female life 
expectancy than in male life expectancy only in the case of vaccine-preventable diseases. 
For non-vaccine-preventable diseases the corresponding interaction coefficient is statisti-
cally insignificant. This result is not surprising given the extensive evidence from the 
medical literature, summarized in Sect. 2, regarding the higher efficacy of vaccines among 
females. From all IET-related medical advances, vaccines are the ones that most likely ben-
efited women more than men. As a consequence, countries where the IET-related mortality 
reductions were more closely related with the introduction and diffusion of vaccines are the 
ones expected to experience relatively larger increases in female life expectancy.
Interpreting the magnitudes of the estimated coefficients in column 3, we find that male 
life expectancy rose on average by 4.2 years and female life expectancy by 6 years, as a 
consequence of the improved control methods of vaccine-preventable diseases. This means 
that the effect for females is 43% higher than that for males. Looking at the corresponding 
magnitudes for non-vaccine-preventable diseases instead, we find that the potential mortal-
ity reductions were associated with increases in life expectancy on average by 1.5 years 
for females and by 1.2 years for males, with the difference between the two being statisti-
cally insignificant.12 Taken together, these figures imply that out of the actual differential 
life expectancy gain of 2.76 years between men and women observed on average in our 
sample, 2.2 years can be explained by the overall reductions in mortality from infectious 
diseases and 1.8 years can be explained solely by the reductions in mortality from vaccine-
preventable diseases.
In columns 4, 5 and 6 we present the estimation results for the same regression speci-
fication when using instead the alternative potential mortality instruments. These are con-
structed assuming that potential mortality rates in 1980 are not zero, but follow the alter-
native assumptions described in Sect.  4. Specifically for the estimation in column 4 we 
12 While the point estimate of −5.6 on the interaction term appears large, the actual magnitude of the effect 
is quantitatively not important as the variation in mortality rates for the NVP-group in our sample is not 
very high. This can be seen better in Table A3 in the appendix, where we report the estimates for the same 
regression with standardized coefficients.
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assume that mortality rates in all countries fell proportionately to the global average, for 
the estimation in column 5 we assume that mortality rates fell to the levels observed in the 
United States in 1980 and for the estimation in column 6 we assume that mortality rates 
fell to the average levels observed in other health-frontier countries in 1980. In all cases the 
estimation results are very similar to the results reported in column 3. Together they further 
corroborate the clearly stronger response of female life expectancy to mortality improve-
ments related to vaccination, but not to other methods of disease control.
Turning to panel B of Table 3, we can see the second-stage estimates of the 2SLS esti-
mations that correspond to the first-stage estimates described above. The results in all cases 
are very similar. Irrespective of the exact setup employed in the first stage, the second-stage 
estimates suggest that improvements in life expectancy between 1940 and 1980 led to sta-
tistically significant increases in average years of schooling. Also when estimating Eq. (1) 
with ordinary least squares (OLS), as reported in column 7, we obtain a positive coefficient 
of similar magnitude. The last row of the table shows the first-stage effective F-statistic 
proposed by Montiel-Olea and Pflueger (2013), which is appropriate for our panel setup 
with clustered standard errors. Looking at the critical values of the test suggests that our 
regressions do not suffer from a weak instruments problem as the resulting bias of the 
2SLS estimates relative to OLS is always below 20%.13
While in our second-stage estimation we obtain a common life-expectancy coefficient 
for both males and females, our estimates still imply that the mortality reductions associ-
ated with the IET gave rise to larger increases in average years of schooling for females 
than for males.14 This is because in the first-stage estimation we have already shown that 
the same potential mortality reductions from the diffusion of IET-related medical advances 
led to larger gains in life expectancy for females than for males. In particular, the coefficient 
estimate of 0.115 in column 2 in combination with the changes in life expectancy predicted 
from the first stage regression imply increases in schooling, on average, of 0.65 years for 
males and 0.9 years for females. This corresponds to a reduction of 0.25 years in the educa-
tion gender gap, which is 80% of the actually observed reduction over our sample period.
An alternative way to assess the differential effect of the IET-related medical advances 
on male and female schooling is to estimate the reduced-form relationship between our 
potential mortality instrument and average years of schooling. This is done in columns 8, 
9 and 10 of Table 3. In column 8 we present the reduced-form regression using potential 
mortality from all infectious diseases, in column 9 we interact potential mortality from all 
diseases with the female dummy and in column 10 we further distinguish potential mortal-
ity stemming from the VP and NVP groups of diseases. In all cases the obtained reduced-
form estimates confirm the conclusions that emerge from the 2SLS results. Reductions in 
potential mortality are associated with increases in schooling overall and these increases 
are higher for women than for men. Moreover, this differential effect appears to be driven 
by mortality reductions from VP diseases. The effect of mortality reductions from NVP 
13 Looking alternatively at the corresponding partial R-squared for the instruments in the first-stage regres-
sions also does not provide an indication of a weak instruments problem. Our set of instruments jointly 
explains about 50% of the variation in life expectancy in the different specifications of Table 3.
14 In Sect. 7.2 we formally test for potential heterogeneity between men and women in the estimated rela-
tionship between life expectancy and years of schooling, but we find no evidence for that. The estimation 
results can be seen in Table 8.
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diseases is not only statistically insignificant, but also quantitatively small when evaluated 
in terms of its implied magnitude.15
Comparing the magnitudes of our estimates with previous work in the literature is also 
reassuring. Our second-stage estimates suggest that one extra year of life led to an increase 
in schooling by 0.115 years. This is almost identical to the effect size of 0.11 reported by 
Hansen (2013), who estimates a similar specification over the same time period, but looks 
at average years of schooling for the whole population, without distinguishing between 
men and women. Similar effects are also found by Jayachandran and Lleras-Muney (2009), 
who report effect sizes between 0.11 and 0.15 years of schooling for each additional year of 
life from improvements in maternal mortality.
Alternatively, we can look at the implied elasticities for the response of schooling to 
changes in life expectancy. These elasticities are found to be between 0.6 and 1 by Jay-
achandran and Lleras-Muney (2009) based on data from Sri Lanka, and between 0.8 and 
1.3 by Oster et al. (2013) based on data from the United States.16 Given the initial levels of 
life expectancy and schooling in our cross-country sample, we find that on average mortal-
ity reductions associated with the IET increased life expectancy by 16% for women and 
12% for men. This in turn resulted in a 21% increase in average years of schooling for 
females and a 14% increase for males, which implies an elasticity of 1.18 for males and 
1.34 for females.
6  Robustness checks
Having demonstrated in our baseline regressions the quantitative importance and the sta-
tistical significance of the link between the differential health improvements across genders 
associated with the IET and the evolution of the education gender gap, we proceed in this 
section to establish the robustness our finding. For this purpose, we first check carefully 
our first-stage estimation by comparing mortality rates from different groups of infectious 
diseases, by controlling for mortality rates from other important causes of death and by 
employing gender-specific mortality rates. We then scrutinize our second-stage estima-
tion by contrasting the effects for different cohorts and alternative measures of educational 
attainment. Further robustness checks related to the composition of our country sample, 
the employed regression specification and the time periods of our analysis are provided in 
the appendix.
6.1  Different groupings of infectious diseases
If improvements in mortality due to the introduction of vaccines led to larger life expec-
tancy gains for females than for males, as established in our first-stage estimation, then this 
pattern should be observable with mortality rates for individual diseases as well as for sub-
groups of diseases. With that in mind, in columns 1, 2 and 3 of Table 4 we repeat our first-
stage estimation focusing on potential changes in mortality from the three most important 
15 These regressions are also reported with standardized coefficients in Table A4 in the appendix, which 
permit such comparisons more easily.
16 Bleakley (2018) reviews several empirical papers on the effect of health on education and also concludes 
that typical estimates of the health-education elasticity are around 1.
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infectious diseases of that time: malaria, pneumonia and tuberculosis. Doing so is instruc-
tive as these three diseases together account for 87% of mortality from the 13 infectious 
diseases in 1940. In each of the three columns we report the effect on life expectancy of the 
potential changes in mortality from one of the three diseases, as indicated in the top part of 
the table, while controlling at the same time for the potential changes in mortality from the 
remaining 12 diseases with the residual mortality variable.
Comparing the estimation results across the three columns, we see that the interaction 
term between the female dummy and potential mortality is statistically insignificant for the 
case of malaria, but negative and statistically significant for pneumonia and tuberculosis. 
These results are in line with our earlier conclusion that the relatively larger gains in female 
life expectancy over this period were driven by the stronger immune responses of females 
to vaccination. As we explain in greater detail in Section C of the appendix, both pneumo-
nia and tuberculosis are diseases for which vaccines played a role as a method of control 
after 1940. Malaria, on the other hand, was largely controlled by newly developed insecti-
cides, such as DDT, and to this date no effective vaccine against it exists.
Given the importance of these three diseases over our sample period, we need to ensure 
that our results are not driven by a differential response of females to potential changes in 
mortality from just these three diseases. Therefore, in column 4 we focus on the remaining 
ten diseases, splitting them once again into a group of diseases that effectively became vac-
cine-preventable after 1940 and a group of diseases that did not. In line with the previous 
estimations, we also control for potential mortality changes from the three major diseases 
with the residual mortality variable. As the results demonstrate, we see again a clear dif-
ferential change in female life expectancy resulting from potential reductions in mortality 
from diseases of the VP group, even with pneumonia and tuberculosis excluded, but not 
from diseases of the NVP group.17,18
A related concern with our results is the fact that mortality from diseases in the VP 
group was on average higher in 1940 than mortality from diseases in the NVP group. To 
address this concern, we have collected additional data on mortality from diarrhea in 1940, 
which is the most important infectious disease not covered in the data set of Acemoglu and 
Johnson (2007). Its death toll in 1940 was about 17% of the death toll from all other infec-
tious diseases in our sample. Diarrhea also clearly falls in the NVP group of diseases, as 
no vaccine for any form of diarrhea existed during our sample period. The reason why we 
do not include diarrhea in our baseline mortality measure is because the available data for 
diarrheal mortality in 1940 only cover 43 out of the 75 countries in our sample.
Focusing on these 43 countries, however, we can check whether potential reductions in 
mortality from diarrhea had differential effects on female and male life expectancy. As we 
can see from column 5 of Table 4, this is clearly not the case. The estimated coefficient of 
the interaction term with the female dummy is statistically insignificant. Furthermore, we 
can re-estimate our main specification with diarrhea included in the NVP group of dis-
eases. Looking at the estimates reported in column 6, we see again that the potential mor-
tality reductions from diseases in the NVP group, even with diarrhea included, do not have 
a clear differential effect on female and male life expectancy.
17 The coefficient estimate is only marginally below conventional levels of statistical significance with a p 
value of 0.12.
18 In results not reported for brevity we also exclude from the potential mortality instrument one-by-one 
each of the diseases and show that our results are not driven solely by any specific disease.
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A final concern regarding our first-stage estimation is that the observed differential 
gains in life expectancy for females and males may be due to variation in the causative 
agent behind each disease rather than the method of disease control. While the medical lit-
erature has not documented any differences in the immune response of females and males 
across different types of causative agents, we nevertheless test for this. For this purpose 
we separate the 13 diseases with respect to their causative agent (bacteria, viruses, para-
sites) as well as their main method of control. As all viral diseases in our data set (influ-
enza, measles, smallpox) are vaccine-preventable and malaria is the only parasitic disease, 
for this robustness check we focus on just bacterial diseases. In column 7 we separate the 
nine bacterial diseases in our data set into vaccine- and non-vaccine-preventable ones and 
interact the potential mortality rates from these two groups of diseases with the female 
dummy. As before, we control at the same time for the changes in potential mortality from 
the remaining four non-bacterial diseases with the residual mortality variable. Once again 
we find only potential mortality reductions from vaccine-preventable bacterial diseases to 
be associated with larger gains in life expectancy for females than for males. The patterns 
that we observe, hence, do not appear to be driven by the causative agent behind the differ-
ent infectious diseases.
Looking at the second-stage estimates across the different columns of Table 4, we see 
that the effects of life expectancy on average years of schooling that we obtain are not very 
different from our baseline estimation in column 3 of Table 3. Only in columns 5 and 6 we 
obtain a substantially higher coefficient, which is solely driven by the change in the sample 
composition.19 Thus, we can safely conclude that the 2SLS estimates of the relationship 
between life expectancy and average years of schooling do not hinge on the exact set of 
infectious diseases that we consider for the first-stage estimation.
6.2  Other sources of mortality
In our discussion of the first-stage estimation results we have focused on the effects that 
potential reductions in mortality from infectious diseases had on male and female life 
expectancy. Yet, the observed changes in life expectancy between 1940 and 1980 were not 
just driven by changing mortality from infectious diseases, but also by changes in other 
causes of death. Given this fact, in Table 5 we control for changes in mortality from two 
other important causes of death. These are maternal mortality, whose importance has been 
highlighted among others by Albanesi and Olivetti (2016), and mortality from cancer and 
cardiovascular diseases, emphasized by Deaton (2003). These sources of mortality are of 
particular importance, as they changed dramatically over the sample period, with maternal 
mortality falling and mortality from cancer and cardiovascular diseases rising. Moreover, 
these causes of death exhibit clear gender-specific patterns with maternal mortality affect-
ing only women and cancer and cardiovascular diseases being more frequent among men. 
Controlling for these sources of mortality in our first-stage specification in columns 1 and 
2, though, does not alter our main results. Female life expectancy still exhibits a stronger 
response to potential reductions in mortality from vaccine-preventable diseases, but not to 
reductions in mortality from non-vaccine-preventable diseases.
19 Estimating our main specification of column 3 in Table 3 over the sample of 43 countries for which we 
have data on mortality from diarrhea gives a very similar second-stage estimate.














































































































































































































































































































































































































































































































































































































































































































































































































































































60 Journal of Economic Growth (2020) 25:37–86
1 3
Another important concern regarding our first-stage estimation may be the fact that the 
employed mortality data in 1940 are not gender-specific and therefore our potential mortal-
ity instrument does not vary across genders in the same country. We deal with this concern 
in two ways. First, we use gender-specific causes-of-death statistics from the United States, 
published in the U.S. Vital Statistics (Census Bureau 1940), and calculate for each of the 13 
infectious diseases in our sample the U.S. female-to-male mortality ratio in 1940. We then 
use these ratios to convert the population-wide mortality rates for each of the 75 countries 
in our sample to gender-specific ones, assuming that the female-to-male mortality ratio was 
the same as in the United States. As an alternative, we utilize the information provided by 
Preston et al. (1972) who report gender-specific mortality rates from different causes for 22 
of our sample countries at various points in time during the twentieth century.20 Based on 
this information we calculate for each of these countries a female-to-male mortality ratio 
for different groups of infectious diseases and use these country-specific ratios to convert 
the population-wide mortality rates for the 22 countries to gender-specific ones.21
The estimation results with gender-specific mortality rates can be seen in columns 3 and 
4. Column 3 corresponds to the case where we use the mortality rates obtained with the 
first approach and column 4 to the case where we use the second approach.22 In both cases 
we see that using gender-specific mortality rates does not alter the qualitative nature of our 
results. Only quantitatively we do see some changes in the estimated magnitudes for the 
first-stage coefficients. Interestingly, our main coefficient of interest, VPf , is now larger in 
absolute terms and even more statistically significant. This suggests that by not employing 
gender-specific mortality rates in our main regressions we most likely end up underesti-
mating the differential increases in female life expectancy that resulted from the IET. This 
underestimation is most likely caused by the fact that female mortality rates in 1940 were 
already lower than the male rates. As discussed in Sect. 2, this probably has to do with 
the stronger immune response of women to pathogens, making them less susceptible to 
contract infectious diseases and having less severe disease outcomes. Using the mortality 
rates for the whole population to construct our mortality instrument will, thus, lead to an 
understatement of the potential mortality reductions faced by males and an overstatement 
of the potential mortality reductions faced by females. As a consequence, any resulting bias 
in our estimation will attenuate our female-specific coefficient VPf  toward zero.
Looking at the second-stage estimates across the different columns of Table 5, we reach 
again similar conclusions regarding the relationship between life expectancy and average 
years of schooling as in our baseline estimates in Table 3. The slightly higher estimated 
coefficients in columns 1 and 2 are again solely driven by changes in the sample composi-
tion rather than by the inclusion of the additional controls. Thus, we can conclude that 
using population-wide rather than gender-specific mortality rates, given the absence of 
comprehensive gender-specific mortality data, does not pose a particular problem other 
than causing potentially an underestimation of the relative changes in male and female 
education.
20 These 22 countries are Australia, Canada, Chile, China, Czech Republic, Denmark, France, Greece, 
Italy, Japan, Netherlands, New Zealand, Norway, Portugal, Slovakia, South Africa, Spain, Sweden, Switzer-
land, Taiwan, United Kingdom and United States.
21 A slight complication in this case is that the data from Preston et al. (1972) do not allow us to compute a 
female–male mortality ratio for each infectious disease separately. In Section B of the appendix we explain 
how we deal with this.
22 In this second case we are forced to reduce the number of included fixed effects due to the small sample 
size. Instead of gender-country fixed effects, we employ separate fixed effects for gender and country.
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6.3  Different cohorts and alternative schooling measures
Having shown that our estimation results do not hinge on the exact specification of our 
first-stage regression, it is instructive to investigate the relationship between life expectancy 
and alternative measures of educational attainment. This is what we focus on in Table 6. In 
column 1 we begin by looking at how the improvements in life expectancy between 1940 
and 1980 affected educational attainment for the cohort of males and females that were 
between the ages of 0 and 9 in each respective year. These are individuals who all started 
school within the ten years after our observation of life expectancy. Similarly, in column 2 
we look at educational attainment for the cohort of males and females that were between 
the ages of 5 and 14 in each respective year and started school within the 5 years before 
and after our observation of life expectancy.
As the only thing that changes in these two specifications, compared to our main one in 
Table 3, is the dependent variable in the second stage, the first stage estimates are the same 
as in column 3 of Table 3. Looking at the second stage estimates, we see that measuring 
average years of schooling based on broader age cohorts yields qualitatively similar results. 
This is reassuring, as it implies that our findings do not hinge on studying the schooling 
outcomes of a particular age cohort. The estimated coefficient reported in column 2 is a bit 
lower, but this is probably driven by the fact that changes in life expectancy between 1940 
and 1980 were less relevant for the older individuals in the cohort that had already com-
pleted part of their education before the full gains in life expectancy were realized.23
Having established this result, in columns 3–5 we proceed to assess whether the link 
between life expectancy and educational attainment operates at all schooling levels or not. 
For this purpose, we use as our dependent variable in the second-stage estimation, instead 
of the average years of schooling, the share of individuals from each cohort that has com-
pleted primary education in column 3, completed secondary education in column 4, and 
completed tertiary education in column 5. While the point estimates in these three cases 
and our baseline setup are not directly comparable, qualitatively the results are similar, 
showing a significant positive effect of life expectancy improvements on completion rates 
at all levels of education.
Specifically, the estimates imply that the improvements in life expectancy observed 
between 1940 and 1980 led on average to a 19 percentage point increase in the primary 
school completion rates of males and to a 21 percentage point increase in that of females. 
For secondary education, the corresponding increases in the completion rates for males 
and females are 1.8 and 2.3 percentage points respectively, while at the tertiary level they 
are 0.3 and 0.7 percentage points. These figures suggest that the global health improve-
ments over the post-war period had the largest impact on primary education. This is not 
surprising given that many of the new methods of controlling infectious diseases benefited 
primarily young children, who may have otherwise been forced to drop out of school at a 
young age or never started school to begin with.24 Given that among cohorts who started 
school around 1940 less than 15% of the population completed secondary education and 
23 To the extent that schooling decisions are primarily influenced by the health environment around the 
time when people enter the school system, the relationship between changes in life expectancy at birth and 
average years of schooling between 1940 and 1980 should be weaker for people of age 5–14 than people of 
age 5–9.
24 This finding is very much in line with evidence summarized in Almond and Currie (2011) regarding the 
large effects of disease exposure in early childhood on schooling outcomes.
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less than 5% completed tertiary education, the relatively larger increases for females in 
terms of primary schooling completion rates over the subsequent 40 years appear as the 
main driver behind the observed changes in the education gender gap.
In the last three columns of Table 6 we repeat the regressions shown in columns 3–5 
for a sub-sample of developing countries.25 The dependent variable in column 6 is again 
the share of a given cohort with completed primary education, in column 7 the share with 
completed secondary education and in column 8 the share with completed tertiary educa-
tion. Overall, the obtained estimates are not very different from those for the full sample. 
For developing countries the effect of life expectancy on primary education is a bit larger 
in magnitude, while the effects on secondary and tertiary education are slightly weaker 
and statistically insignificant. The differences, however, are small and they could simply be 
driven by the differential quality of the data.
7  Comparing the relevance of different factors and mechanisms
Having established the robustness of our main findings regarding the role of the health 
improvements associated with the IET on the evolution of the education gender gap 
over the post-war period, in this section we proceed to compare its relevance to other 
explanations for the post-war expansion of schooling and female schooling in particular. 
For this purpose we control in our main specification for changes in other variables that 
have been associated in the literature with health and educational outcomes of males 
and females. Furthermore, we investigate whether the observed differential changes in 
educational attainment across genders could be attributed to differences in the health-
education elasticity between men and women. Lastly, we expand our analysis consider-
ing alternative measures of life expectancy and other indicators of health.
7.1  Exploring the role of additional control variables
In the regression results that we have presented up to this point we have ignored the role 
played by other factors that may have influenced the evolution of health and educational 
outcomes of men and women over our sample period and the estimated relationship 
between the two. With that in mind, in Table  7 we include in our main specification 
various control variables that reflect such factors and explore whether their inclusion 
affects our main findings. All details regarding the construction of these variables are 
provided in Section B of the appendix.
In column 1 we control for each country’s level of GDP per capita in both the first- 
and second-stage of our estimation. Economic development is bound to have a positive 
effect on both life expectancy and schooling. As the estimation results reveal, however, 
controlling for GDP per capita does not alter our main findings. In the first-stage estima-
tion the coefficient on GDP per capita is not statistically different from zero. Its inclu-
sion also does not change the key pattern in the first-stage estimation with potential 
25 We classify as developed all countries in which in 1940 less than 25% of the labor force was employed 
in agriculture. Using an alternative criterion based on GDP per capita, as in Acemoglu and Johnson (2007), 
does not alter the set of countries that are classified as developed.
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mortality reductions from vaccine-preventable infectious diseases being associated with 
relatively larger increases in female life expectancy. In the second-stage estimation, 
GDP per capita is positively associated with average years of schooling, confirming the 
role of economic development in fostering educational attainment. In spite of that, its 
inclusion appears to increase the quantitative importance of the effect of life expectancy 
on educational attainment rather than reduce it.
In column 2 we control for the quality of institutions in each country, measured by 
the constraints on the executive score from the Polity IV database. As we can see from 
the results, on average countries with better institutions experienced smaller gains in life 
expectancy. Controlling for this effect of institutional quality, however, we still observe 
in the first stage a differential change in female and male life expectancy. In the second 
stage the coefficient on institutional quality is insignificant and does not alter the rela-
tionship between life expectancy and schooling.
Considering that educational attainment may be influenced also by the concentration 
of population in cities, in column 3 we control for urbanization. Specifically, we meas-
ure each country’s urbanization rate in 1950 and 1990 to see whether changes in that 
rate relate to the observed changes in schooling, which are also measured in 1950 and 
1990, as explained in Sect. 4. Including this variable does not alter our main findings. 
Moreover, the coefficient estimates for the urbanization rate are statistically insignificant 
both in the first and in the second stage.
In column 4 we consider the role played by the sectorial structure of the economy, in 
particular the size of the service sector. This is to capture the idea that structural change 
may have led to a higher demand for schooling. As we did in the case of the urbanization 
rate, we collected data on each country’s share of employment in the service sector in 1950 
and 1990. We find the service-sector employment variable to be significant in the first-
stage estimation, but not in the second-stage. In either case, its inclusion does not change 
the estimates for our main coefficients of interest.
Another important factor that could be important in this context are country laws about 
compulsory schooling. As over the post-war period there were important changes in these 
laws, it is conceivable that these changes may have influenced the observed expansion of 
schooling and the closing of the gender gap. To assess this, in column 5 we control for 
the years of compulsory schooling in each country in 1950 and 1990, which once again 
is in line with the years in which we measure average years of schooling. As we can see 
from the second-stage regression results, there is a clear positive association between the 
post-war expansion of compulsory schooling and the observed increases in average years 
of schooling. From the first-stage results we also see that the expansion of compulsory 
schooling is positively related with the observed improvements in life expectancy. Never-
theless, the inclusion of this variable does not alter our main results and its effect appears 
to be largely complementary to that of health improvements.
In column 6 we consider the role of voting rights for women, which relate to broader 
changes in the legal status of women and which have been emphasized by many authors in 
the literature.26 To control for this channel, we include in our specification a dummy varia-
ble reflecting whether women had the right to vote in the respective sample year. As we can 
see in panel A, this variable is positively associated with life expectancy, but its inclusion 
does not affect the link between life expectancy and the mortality reductions associated 
26 See Doepke et al. (2012) for a summary of the literature.
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with the IET. The variable is also positively correlated with average years of schooling, as 
we can see in panel B. However, the estimated coefficient is statistically insignificant and 
its inclusion does not overturn the positive effect of life expectancy in the second stage.
In column 7 we explore the role that characteristics of the marriage market played in 
the educational choices made by males and females. This relates to arguments regarding 
the importance of education in the marriage market presented by Chiappori et al. (2009) 
in the case of developed countries as well as Ashraf et al. (2016) in the case of developing 
countries. To capture this idea we control for the ratio of divorces to marriages in 1950 
and 1990 respectively. This variable reflects the likelihood of individuals experiencing a 
divorce relative to that of getting married. While the first-stage estimates in this case sug-
gest that countries in which divorce rates grew faster relative to marriage rates experienced 
smaller gains in life expectancy, including this variable in the specification does not change 
the key coefficients of interest. It also does not alter qualitatively the relationship between 
life expectancy and schooling.27
In column 8 we investigate the role played by changes in the labor force participation 
of males and females over our sample period. This is motivated by the argument made by 
Goldin (2006) that improved labor market conditions for women increased their returns 
to schooling in comparison to men. To account for this effect, we collect data for the eco-
nomic activity rates of males and females in 1950 and 1990 and include them in our speci-
fication as a control. Our regression results in this case suggest that while this mechanism 
may have been important in the case of some developed countries, such as the United 
States, in the context of our broad country-sample it does not appear to be quantitatively 
important. Moreover, controlling for it does not alter the observed patterns for the remain-
ing variables, neither in the first stage nor in the second stage.
In columns 9 and 10 we assess the importance of changes in fertility behavior over our 
sample period. Theories about the demographic transition clearly link fertility with life 
expectancy and educational attainment.28 With that in mind, in column 9 we control in 
our specification for fertility rates, measured in 1950 and 1990. As the regression results 
indicate, higher fertility rates are associated with lower levels of life expectancy and lower 
levels of educational attainment, in line with demographic transition theories. Controlling 
for this effect, however, does not affect the main regression coefficients, neither in the first 
stage nor in the second stage. In column 10, we also allow the effect of fertility to dif-
fer between high and low income countries. To do so, we interact the fertility rate with a 
dummy variable indicating countries that in 1950 were above the median income level in 
our sample of countries. The positive coefficient estimates for the interaction term signify 
that the adverse effect of fertility on education and the negative correlation between fertil-
ity and life expectancy is more pronounced in poorer countries. Conditioning on that effect 
as well, our main results still hold.
Finally, in column 11 we include in our specification all the control variables that we 
introduced in columns 1–9. For practical reasons we do not display all their coefficient 
27 We also experimented with controlling separately for divorce and marriage rates rather than the ratio of 
the two. The results are very similar and mirror those shown in column 7 with marriages being positively 
correlated with life expectancy and education, and divorces being negatively correlated.
28 As parents face a trade-off between the quantity and the quality of their children, they are more likely 
to invest in their education in a low fertility environment. At the same time, a lower level of fertility also 
implies that mothers have more opportunities to participate in the labor market, which in turn would 
increase the returns to investment in their own education. See Galor (2011) for an overview of the theories 
of the demographic transition.
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estimates, but we only report the p value for the F-test regarding their joint statistical sig-
nificance. As expected from the estimates reported in columns 1–9, this test is rejected, 
indicating that the control variables are jointly significant. Even when we include all con-
trols variables, we still see that changes in potential mortality from vaccine-preventable 
diseases have clearly a stronger effect on the life expectancy of females than males and 
these differential changes in life expectancy are associated with corresponding changes in 
schooling in the second stage.
In sum, the estimation results in Table  7 present a very consistent picture. Our main 
findings are robust to various alternative explanations for the evolution of life expectancy 
and the rise in educational attainment over the post-war period. The statistical significance 
and the quantitative importance of our key parameter estimates are similar across all speci-
fications. There are some fluctuations in the size of the estimated effects of life expectancy 
on schooling, but these fluctuations are mostly due to the change in sample size across col-
umns and not to the inclusion of the control variables.
7.2  Exploring potential heterogeneity in the health‑education elasticity
The main contribution of our empirical analysis has been to document how the evolution of 
the education gender gap that took place over the second half of the twentieth century was 
influenced by the differential health improvements across genders triggered by the IET. 
As women gained more years of life than men, this promoted further female educational 
attainment and led to relatively larger increases in female average years of schooling. While 
the empirical evidence that we have presented so far supports this explanation, it does not 
preclude an alternative explanation that attributes the closing of the education gender gap 
to differential returns to schooling. In this case the larger female schooling increases could 
be the result of women experiencing stronger increases in their returns to schooling com-
pared to men, independently of their health status. In this case, women might choose to 
invest more in their education even if they did not gain more in terms of health than men. 
In this section we assess the plausibility of this alternative explanation in two ways. First, 
we test directly whether the health-education elasticity that we estimate in the second-stage 
specification differs in general between men and women. Second, we explore whether there 
is heterogeneity in the health-education elasticity among the countries in our sample with a 
series of interaction regressions.
The estimation results for these tests are reported in Table 8. For practical reasons we 
only report the second-stage estimation results. We should stress, however, that when 
performing these estimations we treat life expectancy as well as all interaction terms that 
include life expectancy as endogenous and instrument them with our potential mortality 
instrument multiplied with the relevant interaction variable. This implies that we have 
multiple endogenous regressors and multiple first-stage regressions. To alleviate con-
cerns about weak instruments we report for each of the underlying first-stage estimations 
the effective F-test statistic of Montiel-Olea and Pflueger (2013) for the excluded instru-
ments. This allow us to assess the strength of the instruments for each of the endogenous 
regressors.
In column 1 we introduce in our second stage specification an interaction term of life 
expectancy with the female dummy. Looking at the resulting estimates, we see that the 
coefficient on the interaction term is statistically insignificant and effectively zero. This 
implies that the response of female schooling to a given life expectancy increase was not 
different than that of male schooling.
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The finding of a common health-education elasticity for men and women weights 
against the hypothesis of stronger increases in the returns to female schooling. Neverthe-
less, it is still possible that for some countries in our sample the returns to female school-
ing did increase more over the post-war period due to factors other than changes in life 
expectancy. With that in mind, in the remaining columns of the table we interact life expec-
tancy and its interaction with the female dummy with several additional control variables. 
The variables that we use for this exercise include GDP per capita, institutional quality, 
the urbanization rate, the service-sector employment share, years of compulsory school-
ing, female voting rights, abortion laws and fertility.29 We focus on these variables, as they 
may affect in different ways the returns to schooling for men and women and, hence, the 
health-education elasticity.30 To simplify the estimation, we do not construct the interac-
tion effects based on the actual values of the control variables, but based on dummy vari-
ables that take a value of one for countries that are above the median in terms of the respec-
tive control variable and a value of zero otherwise.31
Looking at the estimation results in columns 2–9 we see that none of the coefficients on 
the interaction terms with the additional control variables are statistically significant. This 
suggests that differences in the aforementioned variables across countries did not affect the 
nature of the relationship between life expectancy and years of schooling. Female school-
ing does not appear to be more sensitive or to respond more strongly than male school-
ing to the post-war increases in life expectancy, on average as well in particular countries. 
Hence, we can conclude that the relative rise in female schooling and the closing of the 
education gender gap should be attributed to differential health improvements between 
men and women, and not to differential changes in the returns to schooling.
Having said that, we should note that our analysis does not necessarily preclude any 
differences in the returns to schooling between men and women. Persistent differences in 
the returns to schooling across genders in any of our sample countries, which may account 
for level differences in the average years of schooling for males and females, will be picked 
up in our specification by the gender-country fixed effects. This set of fixed effects will 
capture, for example, the role of gender norms and other cultural or institutional attributes 
of countries, which are expected to influence health and educational outcomes of men and 
women and which have been shown to be highly persistent (Alesina et al. 2013; Hansen 
et al. 2015). At the same time, there are common factors that played a role in the relative 
rise of female education over our period of interest, such as the introduction of the birth 
control pill, stressed by Goldin and Katz (2002), or the decline in the price of household 
appliances, highlighted by Greenwood et al. (2016), which we do not explicitly consider. In 
the context of our analysis, the effect of these common factors would be largely captured 
by the year fixed effects.32
29 Details regarding the measurement and data sources for these variables are provided in Section B of the 
appendix.
30 See, for example, the arguments along these lines made by Bloom et al. (2009) regarding abortion laws 
and Murphy (2015) regarding fertility.
31 In the case of time-varying control variables we take their initial values to construct the corresponding 
dummy variable.
32 The birth control pill is a good example of a common factor whose impact diffused across countries 
during the period under study. It was first approved by the FDA in 1957 and by 1990, the year in which we 
observe the educational attainment of our 1980 school cohort, it was available for use in all 75 of the coun-
tries in our sample apart from Myanmar (Finlay et al. 2012).
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7.3  Comparing the effects for life expectancy at different ages and other health 
indicators
Our analysis up to this point has been focused on estimating the effect of life expectancy at 
birth on average years of schooling. We focus on life expectancy at birth as it is the most 
commonly used measure of the overall health status of a country’s population. Yet, changes 
in the mortality environment may have different effects on the health status of individuals 
depending on their ages. Moreover, the IET may also have affected other dimensions of 
health that are not fully captured by life expectancy. As these may be important for edu-
cational attainment, in this section we broaden our analysis to consider life expectancy at 
different ages and other indicators of health.
We begin in columns 1 and 2 of Table 9 by conducting our 2SLS estimation using life 
expectancy at age 5 and age 10 instead of life expectancy at birth. Using these life expec-
tancy measures allows us to exclude the effects that the IET had on the survival rates of 
infants and very young children and focus on its impact from the age of schooling onward. 
Despite limited data availability, which forces us to conduct our analysis with a smaller 
sample, the results that we obtain are both qualitatively and quantitatively similar to our 
baseline results with life expectancy at birth. Potential mortality reductions from both dis-
ease groups led also to improvements in life expectancy at age 5 and 10 and there is a clear 
differential effect on female life expectancy of potential mortality reductions from vaccine-
preventable diseases. The estimated coefficients in the second stage appear slightly higher. 
This is driven by two things. The change in the sample composition and the smaller coef-
ficient estimates in the first stage. The latter implies that the variation in life expectancy at 
age 5 or 10 explained by our mortality instrument is smaller than in our baseline estimation 
using life expectancy at birth. Qualitatively, however, the patterns in the first and second 
stage estimation are unchanged.
In columns 3 and 4 we investigate how the observed changes in average years of school-
ing of males and females are affected by health improvements during childhood versus 
adulthood. For this purpose, in column 3, we focus on life expectancy between the ages 
of 0 and 15 and in column 4 on life expectancy between the ages of 15 and 60. Again, 
due to data limitations, we are forced to work with a smaller country sample. Looking at 
the first-stage estimates, we see clearly that potential mortality reductions from both dis-
ease groups contributed positively to the rise in both child and adult life expectancy. When 
the dependent variable is life expectancy during childhood, the interaction effects with the 
female dummy are insignificant for both disease groups. When the dependent variable is 
life expectancy during adulthood, though, the interaction effect with the female dummy 
is significant for the vaccine-preventable disease group, as in our main specification, and 
insignificant for the non-vaccine-preventable disease group. This is not surprising given 
the evidence provided by the medical literature, which we discussed in Sect. 2. Differences 
in the immune response to vaccines between males and females have been shown to be 
largely related to sex hormones. Hence, we would expect to observe them primarily during 
reproductive ages when differences in hormones between men and women are largest. Our 
results are also consistent with the studies reported in Sect.  2 that have documented the 
absence of gender differences in vaccine efficacy in pre-pubertal children.
Turning our attention to the second-stage estimates, we see that life expectancy increases 
during both childhood and adulthood are clearly associated with schooling increases. 
Thus, educational attainment over the post-war period appears responsive to improve-
ments in child as well as adult health. Looking at the point estimates for the second-stage 
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coefficients, it seems as if the effect of health improvements in children is larger than that 
of health improvements in adults. When expressed in terms of standard deviation changes, 
though, the effects are similar in magnitude with a standardized effect of 0.65 in the case 
of child health and 0.6 in the case of adult health. The estimates of column 4 are consist-
ent with the standard Ben-Porath mechanism, which suggests that improvements in adult 
life expectancy foster education investments by individuals, as they expand the time hori-
zon over which the returns from these investments can be earned. At the same time, the 
estimates of column 3 lend support to alternative mechanisms, such as those proposed by 
Kalemli-Ozcan (2002) and Hazan and Zoabi (2006), according to which improvements in 
child health encourage parents to invest more in the education of their children as their 
chances of survival to adulthood increase.
In columns 5 and 6 we try to distinguish between the effect of health improvements 
related to mortality and those related to morbidity. To do so, we collected data on infec-
tious disease incidences. While these data are only available for some of our sample coun-
tries and part of the period under consideration in our analysis, they allow us to control 
for changes in disease incidence in our main specification.33 In column 5, we include as a 
control variable in our main regression specification the disease incidence rate, measured 
as the average number of incidences over each country’s population, for 8 out of the 13 
infectious diseases in our data. As we can see, disease incidence enters with a negative 
coefficient in both the first and the second stage regression. In the first stage this is not 
surprising, as it implies that our potential mortality instrument leaves out other important 
sources of health improvements which seem to be correlated with the disease incidence 
rate. More interestingly, in the second stage we see that the observed reduction in diseases 
incidences over the period was associated with an increase in educational attainment after 
accounting for the effect of life expectancy.
In column 6 we use as an alternative control variable in our specification the average 
case fatality ratio, which is constructed based on the above-described disease incidence 
data. It measures the ratio of total deaths from all diseases over the total number of inci-
dences. Looking at the estimation results, we see that changes in the case fatality ratio do 
not have any major effects on life expectancy at birth in the first stage regression or on 
average years of schooling in the second stage. The estimated coefficients are statistically 
insignificant and their inclusion does not seem to alter the estimates for the remaining vari-
ables. This suggests that our results are not driven by some infectious diseases becoming 
more or less fatal.
Finally in column 7 we include in our main specification adult height as a control vari-
able to proxy for health improvements unrelated to mortality. Average height is a com-
monly-used indicator of population health in the literature (Weil 2014) and has been 
shown to coevolve with the level of economic development (Dalgaard and Strulik 2015).34 
Moreover, the advantage of using height data is that they are available already in 1940 
and cover all of our sample countries. Including height in our first-stage specification does 
not affect or influence the estimated relationship between changes in potential mortality 
and life expectancy at birth, neither on average nor for women in particular. However, in 
33 Information on disease incidences is collected from various editions of the WHO World Health Statistics 
Annuals. As explained in more detail in Section B of the appendix, these data are only available between 
1965 and 1980 and cover 8 of the 13 infectious diseases that we consider in our analysis.
34 In particular, as shown by Dalgaard and Strulik (2015), average height is expected to rise as economies 
start to develop and experience the demographic transition.
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our second-stage regression the estimated coefficient on height is positive and statistically 
significant. This suggests that increases in height are associated with increase in schooling 
conditional on the effect of life expectancy.
Overall, the results presented in Table  9 suggest that life expectancy at birth is cap-
turing only part of the effect of health improvements on educational attainment. This is 
not surprising as life expectancy at birth only measures health improvements reflected in 
mortality and hence may not fully capture all the improvements in global health that took 
place during the post-war period as a consequence of the IET. As highlighted by Hazan 
and Zoabi (2006), educational attainment may also be fostered by health improvements 
which are unrelated to mortality and not reflected in our life expectancy measure. Hence, 
our baseline estimates are likely to understate the true importance of health improvements 
in influencing the educational attainment of men and women.
8  Evidence from U.S. States
The analysis that we have conducted up to this point uses variation in the mortality envi-
ronment across countries prior to the IET in order to estimate the effect that changes in life 
expectancy of men and women had on their educational attainment and, as a result, on the 
education gender gap. Yet, systematic differences in the mortality environment before the 
IET were not only present across countries, but also within countries. With that in mind, in 
this section we conduct a similar empirical exercise which exploits variation in mortality 
from infectious diseases across U.S. states.
While the mortality transition in the United States had already started before 1940 
(Cutler and Miller 2005; Goldin and Lleras-Muney 2018), the U.S. witnessed sizeable 
improvements in mortality from the late 1930s onward. These improvements were driven 
by medical innovations related to the IET, which spread gradually across the country (Jay-
achandran et al. 2010; Hansen 2014). Hence, our empirical setup is still applicable. Moreo-
ver, conducting our analysis based on data from U.S. states has some further advantages. 
First, it allows us to compare changes across geographical units with similar health and 
education systems. Second, it enable us to use the detailed U.S. causes-of-death statistics, 
which are collected and reported based on a uniform system of death registrations stratified 
by different social groups including gender and race.35 Below we briefly describe the data 
sources that we use to construct our state-level data set and then present the findings from 
the estimation of our main specification.
8.1  Data
To conduct our analysis we build a two-period panel data set with information on aver-
age years of schooling, life expectancy at birth and mortality rates from different infec-
tious diseases for men and women in the 48 contiguous U.S. states and the District of 
35 The United States has had a nationwide system of death registration covering all U.S. states, with the 
exception of Alaska and Hawaii, since 1933.
75Journal of Economic Growth (2020) 25:37–86 
1 3
Columbia.36 For comparability with our global analysis, we focus again on the years 1940 
and 1980.37
As in our global data set, we measure educational attainment in terms of the average 
years of schooling of individuals who were 5–9 years old in the sample years. We con-
struct this measure for the male and female population based on the 1% U.S. census data 
provided by IPUMS (Ruggles et  al. 2019). For this purpose, we convert the categorical 
information on educational attainment reported in the census to average years of schooling 
using the approach explained in Section B of the appendix. The data on life expectancy at 
birth for 1940 are taken from the State Life Tables 1939–1941, published by the Federal 
Security Agency, and the data for 1980 are taken from the U.S. Decennial Life Tables for 
1979–1981. As the 1940 figures are only available for the white population, we also use for 
1980 the data for the white population.
Mortality rates for infectious diseases in 1940 are computed based on the causes-of-
death statistics reported in the 1940 Vital Statistics of the United States, which are strati-
fied by gender and race. To ensure comparability with out global analysis, we focus on the 
same 13 diseases plus diarrhea.38 For consistency with our life expectancy data, we focus 
solely on deaths statistics for whites. For 1980, we follow the same approach we took in 
our estimation with the country sample and assume that the mortality rates for all diseases 
were zero for men and women in all states. This implies that, once again, our mortality fig-
ures will reflect potential changes rather than actual changes in mortality.
8.2  Regression results
Using the above described data set, we estimate our main 2SLS specification outlined in 
Sect. 3. The estimation results are reported in Table 10, with panel A presenting the esti-
mates for the first-stage and panel B the estimates for the second-stage. We begin in col-
umns 1 and 2 with the case where we sum up the mortality rates from all 14 diseases. 
In column 1, we employ mortality data that are not gender-specific, in order to allow for 
direct comparison with our baseline results in Table 3. In column 2, we report the same 
regression based on gender-specific mortality rates. The results obtained in the two col-
umns are qualitatively similar. In both cases we find reductions in potential mortality rates 
from infectious diseases to be associated with increases in life expectancy and this relation-
ship to be stronger for women. Quantitatively, though, the obtained estimates in column 2 
are slightly higher.
In column 3 and 4 we split the potential mortality rates between the VP and the NVP 
disease groups. We do that first with the non-gender-specific mortality rates in column 3 
and then with the gender-specific ones in column 4. In both cases we see that the interac-
tion term with the female dummy is significant and negative for mortality from the VP 
group, but it is statistically insignificant for mortality from the NVP group. This con-
firms our finding from the country-level analysis. Potential mortality reductions from 
36 We exclude Alaska and Hawaii from our analysis as comparable data series for these states are not avail-
able in 1940.
37 Using an earlier starting year, such as 1935, yields similar results.
38 We include diarrhea in our analysis and consider it as part of the NVP disease group, as we did in 
Table  4. This is to ensure that the magnitudes of mortality for the VP and the NVP disease groups are 
somewhat comparable and to rule out that any differences in the observed effects for these two groups of 
diseases are just due to differences in the scale of mortality between the two groups.
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vaccine-preventable diseases were associated with larger increases in female life expec-
tancy than in male life expectancy. But this was not the case for mortality reductions from 
non-vaccine preventable diseases. Comparing the obtained coefficients in columns 3 and 4, 
we see that the estimate for the female-specific effect is larger in absolute magnitude when 
using the gender-specific potential mortality rates. This mirrors the comparison between 
the estimates of column 3 in Table  3 and column 3 in Table  4, which we discussed in 
Sect. 6.2.
Looking more carefully at the magnitudes of the estimated effects in Table 10, we find 
them to be similar to those of the global sample. While at a first glance the coefficients 
in Table 10 appear larger in absolute terms than those in Table 3, this is counterbalanced 
by the lower variation in the variables in the U.S. states sample. Expressed in terms of 
standard deviations, our estimates imply that a one standard deviation reduction in mor-
tality from all 14 infectious diseases combined is associated with a 0.27 standard devia-
tion increase in life expectancy on average across U.S. states. This is similar to the 0.33 
standard deviation increase we found across countries. In terms of implied magnitudes, the 
coefficient estimates in column 1 imply that in response to the changes in potential mortal-
ity male life expectancy increased on average by 1.5 years and female life expectancy by 
4.2 years. If we employ the gender-specific mortality rates in column 2, the implied effect 
sizes are 1.6 years for men and 4.3 years for women.
Turning to the second-stage estimates reported in panel B, we see that, independently of 
how we specify the first stage regression, the life expectancy changes are associated with 
significant increases in schooling. Depending on which first-stage specification we employ, 
we find that one additional year of life is association with 0.166–0.179 additional years of 
schooling. This is higher than the OLS coefficient, which we report in column 5, and is 
similar to what we saw in Table 3. Combining the coefficient estimate of 0.17 in column 1 
with the increases in life expectancy predicted by the first-stage regression, we find that on 
average the medical advances associated with the IET contributed to schooling increases of 
0.72 years for women and 0.25 years for men.
In columns 6–9, we present the estimates for the corresponding reduced-form regres-
sions as in Table 3. As we did with the 2SLS regressions, we conduct the estimation using 
population-wide and gender-specific mortality rates. In both cases we see that female 
schooling responded more strongly than male schooling to the potential improvements in 
mortality. Moreover, when we separate the effects of mortality reductions between the VP 
and the NVP disease groups, we see again that the differential effect is driven by potential 
changes in mortality from diseases of the VP group. In the case of diseases of the NVP 
group we find the interaction effect to be statistically insignificant.
Overall, the results that we obtain based on the U.S. states data lead to similar con-
clusions as the results with the cross-country data. Health improvements for women were 
clearly larger than for men in the second half of the twentieth century. These differential 
changes in male and female health were largely driven by reductions in mortality from 
infectious diseases that became preventable with the help of vaccines. Moreover, these dif-
ferential health improvements played an important role in the relative rise in female edu-
cational attainment. At the same time, the comparison between the obtained estimates 
when using population-wide as opposed to gender-specific mortality rates suggests that the 
implied magnitudes reported in Sect. 5 may even understate the true size of this differential 
effect.
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9  Implications for economic development
With our regression analysis so far we have established that: (a) the global reductions 
in mortality from infectious diseases associated with the IET led to substantial gains in 
life expectancy, (b) these gains led to sizeable increases in years of schooling of men and 
women, and (c) women experienced larger life expectancy gains and as a consequence their 
schooling levels rose more than those of men. In this section we explore the broader impli-
cations that these mortality reductions had for economic development.
An extensive body of literature, summarized by Deaton (2003) and Weil (2014), has high-
lighted various channels through which improvements in health can benefit the process of eco-
nomic development. In the context of the IET-related health improvements, though, Acemo-
glu and Johnson (2007) have demonstrated that countries experiencing largest gains in life 
expectancy were not the ones that gained the most in terms of GDP per capita. This is because 
the resulting increases in total GDP were in many cases offset by increases in the size of the 
population triggered by the lower mortality rates. Cervellati and Sunde (2011) have further 
explored this pattern and have shown that changes in life expectancy did not affect the GDP 
per capita levels of all countries in the same way. In countries that had already experienced the 
demographic transition by 1940 and where fertility was already low, larger gains in life expec-
tancy led to larger increases GDP per capita, as the effects on aggregate GDP were stronger 
than on population. In countries that had not yet experienced the demographic transition, on 
the other hand, larger life expectancy gains did not lead to larger increases in GDP per capita, 
as the effects on population ended up being stronger.
Given our main finding that the IET resulted in differential gains for males and females 
in terms of life expectancy, it is instructive to assess whether these differential gains had 
distinct effects on per capita GDP. In fact, this possibility has already been suggested by 
some work in the literature. The models of the demographic transition proposed by de la 
Croix and van der Donckt (2010) as well as Bloom et al. (2015) highlight how improve-
ments in female health tend to be more conducive to economic development than improve-
ments in male health. This is because health improvements for males and females, while 
both foster educational attainment, have differential effects on fertility and labor force par-
ticipation. An improvement in male health generates primarily an income effect for house-
holds, which increases consumption as well as desired fertility. An improvement in female 
health, on the other hand, has beyond an income effect also a substitution effect for house-
holds, which tends to lower fertility and raise labor force participation. This is due to the 
fact that women naturally devote a larger share of their time to child-rearing activities.
To our knowledge, the existing literature has not provided any empirical evidence on 
these distinct effects that male and female health improvements have on economic devel-
opment. This is largely due to the fact that standard measures of male and female health, 
such as life expectancy, are very highly correlated and their distinct effects cannot be eas-
ily estimated. Our empirical setup, which links the differential improvements in male and 
female life expectancy to the exogenous mortality reductions from vaccine- and non-vac-
cine-preventable diseases, however, allows us to indirectly test how economic development 
is affected by improvements in male and female health. Specifically, this can be done by 
estimating the following reduced-form specification:








Mdct + dc + dt + ect.
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Mdct correspond to the potential mortality rates for the groups of vaccine-prevent-
able (VP) and non-vaccine-preventable (NVP) infectious diseases. The specification 
includes country and year fixed effects, dc and dt, and is estimated in long-differences 
between 1940 and 1980 using a similar sample of countries as in our main regression 
setup.39 If the estimates for bVP and bNVP are negative, this suggests that across countries 
larger reductions in potential mortality from these two groups of diseases were associated 
with larger increases in GDP per capita. This would correspond to the same effects we saw 
in Table 3 that changes in potential mortality had on life expectancy and schooling.
The results of estimating Eq.  (4) can be seen in Table  11. In column 1 we estimate 
first a simpler variant of the specification in which we do not split the diseases into the 
two groups. This way we can assess how the reductions in potential mortality from all 
13 infectious diseases combined affected per capita GDP. The estimated coefficient that 
we obtain in this case is instead positive and statistically significant. This implies that 
39 Out of the 75 countries in our main sample, we have to drop six for which GDP per capita is not avail-
able in 1940.
Table 11  Effects of female and male health improvements on per capita GDP
This table presents reduced-form estimates of the effect of potential mortality reductions from different 
groups of infectious diseases on changes in GDP per capita between 1940 and 1980. In columns (3) to 
(6) the mortality variables are interacted with the interaction variable indicated at the top of the table. All 
regressions include country and year fixed effects. Heteroskedasticity robust standard errors clustered at the 
country level are reported in brackets. ***denotes statistical significance at the 1% level, **at the 5% level, 
and *at the 10% level
Log GDP per Capita
(1) (2) (3) (4) (5) (6)
Interaction variable (I) Post-DT dummy Post-DT dummy Fertility Fertility
Mortality, overall 0.530*** 0.404*** − 3.324***
[0.153] [0.144] [1.061]
I × Mortality, overall − 0.941*** 0.989***
[0.197] [0.274]












Observations 138 138 138 138 138 138
Countries 69 69 69 69 69 69
Within R-squared 0.87 0.87 0.89 0.89 0.89 0.89
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countries experiencing smaller reductions in mortality witnessed larger increases in GDP 
per capita compared to countries experiencing bigger reductions in mortality following the 
IET, which echoes the findings of Acemoglu and Johnson (2007).
In column 2 we proceed to estimate separately the effect of the potential mortality 
reductions coming from the VP and the NVP disease groups. As the estimation results 
indicate, there is a clear positive association between changes in mortality and GDP per 
capita for the NVP group, but a weak and statistically insignificant association for the VP 
group. This implies that the inverse relationship between increases in GDP per capita and 
health improvements, as proxied by potential mortality reductions, occurred largely as a 
result of reductions in mortality from non-vaccine-preventable diseases. In contrast, reduc-
tions in mortality from vaccine-preventable diseases were not inversely related to increases 
in GDP per capita.
In column 3 we explore this pattern further by allowing for differential effects between 
countries that had already experienced the demographic transition (DT) by 1940 and those 
that had not. For this purpose, we follow the country classification of Cervellati and Sunde 
(2011).40 Starting from the specification of column 1 and interacting the changes in poten-
tial mortality from all infectious diseases combined with a dummy variable indicating 
all post-DT countries, we find that the effect of these mortality reductions on per capita 
GDP was different for pre- and post-DT countries. While in the former group of countries, 
reductions in potential mortality were inversely related to changes in GDP per capita, in the 
latter group they were positively related. This confirms the finding of Cervellati and Sunde 
(2011) that the IET-related medical advances were beneficial for economic development in 
countries that had already undergone the demographic transition by 1940.
Column 4 combines the regression specifications of columns 2 and 3 by interacting 
the post-DT dummy separately with potential mortality from the VP and the NVP disease 
groups. As the estimation results in this case indicate, there is a negative and statistically 
significant association between changes in GDP per capita and changes in potential mortal-
ity in post-DT countries. However, this relationship only applies to mortality reductions 
from VP diseases. For NVP diseases the association between changes in GDP per capita 
and changes in potential mortality is positive and statistically significant. These results 
highlight a clear distinction between the effects of the IET-related improvements in mor-
tality for different groups of countries. Post-DT countries that experienced large mortal-
ity reductions from vaccine-preventable diseases clearly gained in terms of income. All 
other countries, however, which either had not yet undergone the demographic transition 
or experienced mortality reductions primarily from non-vaccine-preventable diseases wit-
nessed no income gains.
In columns 5 and 6, we estimate two additional specifications similar to columns 3 and 
4. The difference is that we now use the initial fertility rate in each country as the interac-
tion variable instead of the binary post-DT dummy. This allows us to look more carefully 
at how fertility affected the relationship between changes in mortality and GDP per capita 
by utilizing the full range of fertility rates observed in our sample. The estimates that we 
obtain in this case have the opposite signs, as lower fertility rates were characteristic of 
countries that had achieved the demographic transition. The interpretation, though, is con-
sistent with the results in columns 3 and 4, obtained with the post-DT dummy variable.
40 Specifically, we classify countries as post-transitional if by 1940 life expectancy at birth exceeded 
50 years, there was a sustained decline in fertility, or the crude birth rate had fallen below 30/1000.
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The estimates in column 5 suggest that in countries with initially low levels of fertil-
ity the relationship between changes in potential mortality and changes in GDP per capita 
was on average negative. For these countries the health improvements associated with the 
IET clearly contributed to increases in income levels. In contrast, in countries with initially 
high levels of fertility the estimated relationship between changes in mortality and changes 
in GDP per capita would turn positive. In particular, based on the coefficient estimates 
in column 5, the positive relationship between changes in mortality and income would 
emerge for all countries with fertility rates above 28.8 births per 1000 population, which 
corresponds to about 60% of our sample. For these countries larger mortality reductions 
were associated with smaller increases in GDP per capita. Looking further at the results in 
column 6, we see that the negative association between changes in mortality and income 
in low-fertility countries was only observed in cases of mortality reductions from vaccine-
preventable diseases, consistently with what we found in column 4.
To understand the implications of these results, we should remember that the coun-
tries experiencing larger mortality reductions from vaccine-preventable diseases are also 
the ones where on average females gained more in terms of life expectancy than males. 
With that mind, the results imply that female health improvements are more conducive to 
economic development. This is because, in comparison to similar improvements in male 
health, female health improvements are associated with larger increases in income per cap-
ita. At the same time, the interaction effects with the post-DT dummy or the fertility rate 
suggest that this positive association between changes in health and income will not mate-
rialize in all countries. It will only emerge once a country has achieved the demographic 
transition and freed itself from the pressures of a rising population, for which female health 
improvements also play a role, as we already noted in Sect. 7.1.
10  Conclusion
In this paper we establish a connection between two important developments that took 
place over the second half of the twentieth century: the unprecedented improvements in 
global health and the sharp rise in the educational attainment of women relative to men. 
We argue that both these developments were to a large extent driven by the diffusion of 
western medical innovations around the world after World War II, following the coor-
dinated efforts of the United Nations and the World Health Organization. These efforts 
brought about the so-called International Epidemiological Transition (IET), which led to 
large reductions in mortality from previously highly fatal infectious diseases all over the 
world. While the effect that the IET had on life expectancy across countries is well docu-
mented, the differential nature of the life expectancy gains across genders and their con-
sequences for the evolution of the education gender gap are a novel contribution of our 
analysis.
To establish this connection econometrically and determine the direction of causality, 
we rely on the exogenous nature of the IET-related mortality reductions from the perspec-
tive of individual countries. This exogeneity assumption is justified by the fact that the 
mortality reductions were a product of medical research in a small group of developed 
countries, which diffused rapidly as a result of systematic efforts by international organiza-
tions. In order to establish the differential effect that these medical innovations had on life 
expectancy across genders, we further exploit biological differences in the responsiveness 
of males and females to the different methods of disease control. As the medical literature 
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has recently established, vaccine efficacy is higher among females than among males. 
Hence, health improvements achieved with the introduction of new and improved vaccines 
are bound to be larger for women. This stands in contrast to health improvements achieved 
with methods other than vaccines.
Using this empirical strategy, we document that life expectancy gains across countries 
following the IET were higher among females than among males and that this was particu-
larly the case for gains that can, at least partially, be attributed to vaccines. Moreover, we 
show that the higher life expectancy gains among females led to greater increases in the 
educational attainment of females compared to males and this can explain a substantial 
share of the decline in the education gender gap observed over this period. These findings 
are scrutinized in a series of robustness checks and assessed relative to alternative expla-
nations for the observed patterns. The finding is further supported by a similar empirical 
analysis conducted across states within the United States. Finally, we present evidence sug-
gesting that countries where increases in life expectancy where larger among females than 
among males also witnessed greater increases in their level of GDP per capita over the 
post-war period.
Taken together, these results indicate that improvements in female health do not only 
play an important role in empowering women and promoting gender equality, but also 
benefit the process of economic development. While most of the literature has focused 
on exploring the direct relationship between gender equality and economic development 
(Duflo 2012), our findings suggest that there may be policies that can promote both at the 
same time. These policies may require some time before their impact becomes visible and 
they may also necessitate strong commitments, such as those made by the United Nations 
and the World Health Organization in the 1940s to control infectious diseases. In the long 
run, though, they could prove more effective in achieving gender equality, given the limited 
evidence that this important policy objective can be achieved solely as a by-product of eco-
nomic development.
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